In addition, cPKM can upregulate the expression of STMN1, a gene closely related to tumor occurrence, progression, and paclitaxel resistance,[21, 22, 23] thus enhancing the proliferation, metastasis, and paclitaxel resistance of ICC cells. This evidence concerns the gene STMN1 and intrahepatic cholangiocarcinoma.